7459.T
MEDIPAL HOLDINGS CORPORATION
プライム · 卸売業 · 商社・卸売 · JP
JPY 2,922.50
+0.26%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3775.8B | 3817.4B | 3671.3B | 3558.7B | 3360.0B |
| Cost of Revenue | 880.5B | 3556.4B | 3415.6B | 3312.1B | 3135.7B |
| Gross Profit | 64.7B | 261.0B | 255.8B | 246.7B | 224.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 50.6B | 207.8B | 200.1B | 199.3B | 175.3B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 50.6B | 207.8B | 200.1B | 199.3B | 175.3B |
| Cost and Expenses | 3722.4B | 3764.2B | 3615.7B | 3511.4B | 3311.0B |
| Operating Income (EBIT) | 53.4B | 53.2B | 55.6B | 47.3B | 49.0B |
| Non-Operating | |||||
| Interest Income | — | 234.0M | 50.0M | 29.0M | 101.0M |
| Interest Expense | 3.0M | 13.0M | 7.0M | 8.0M | 34.0M |
| Net Interest Income | (3.0M) | 221.0M | 43.0M | 21.0M | 67.0M |
| Other Non-Op Income/Expense | 4.2B | 22.5B | 9.6B | 17.2B | 16.1B |
| Non-Operating Income (excl Interest) | 4.9B | 25.2B | 16.0B | 19.4B | 17.5B |
| EBT (Pre-Tax Income) | 18.7B | 81.8B | 76.7B | 74.7B | 70.1B |
| Income Tax Expense | 6.1B | 28.7B | 25.2B | 23.0B | 21.7B |
| Bottom Line | |||||
| Net Income | 41.5B | 42.5B | 40.3B | 41.5B | 38.8B |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 41.5B | 42.5B | 40.3B | 41.5B | 38.8B |
| Per Share | |||||
| Basic EPS | ¥200 | ¥207 | ¥193 | ¥196 | ¥185 |
| Diluted EPS | ¥200 | ¥207 | — | — | ¥179 |
| Revenue Per Share | ¥18,314 | ¥18,548 | ¥17,609 | ¥16,804 | ¥16,003 |
| Shares | |||||
| Basic Shares Outstanding | 206.2M | 205.8M | 208.5M | 211.8M | 210.0M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 70.6B | 72.7B | 64.3B | 63.4B |
| D&A | — | 17.4B | 17.1B | 16.9B | 14.4B |
| EBIT | 53.4B | 53.2B | 55.6B | 47.3B | 49.0B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026